Insufficient scRNA-seq data for expression of THPO at single-cell level.
Insufficient scRNA-seq data for expression of THPO at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 1256.14 | 226 / 226 | 94% | 16.93 | 380 / 406 |
| brain | 92% | 197.52 | 2442 / 2642 | 79% | 1.72 | 554 / 705 |
| breast | 98% | 103.97 | 451 / 459 | 60% | 4.26 | 671 / 1118 |
| kidney | 100% | 252.87 | 89 / 89 | 41% | 2.84 | 371 / 901 |
| prostate | 97% | 95.76 | 237 / 245 | 34% | 0.77 | 169 / 502 |
| lung | 92% | 60.30 | 532 / 578 | 30% | 1.99 | 348 / 1155 |
| uterus | 99% | 298.31 | 169 / 170 | 19% | 0.92 | 87 / 459 |
| adrenal gland | 100% | 167.54 | 257 / 258 | 7% | 0.30 | 15 / 230 |
| ovary | 100% | 190.60 | 180 / 180 | 6% | 0.13 | 25 / 430 |
| adipose | 100% | 119.31 | 1199 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 99% | 91.05 | 239 / 241 | 0% | 0 | 0 / 0 |
| bladder | 90% | 68.29 | 19 / 21 | 6% | 0.35 | 29 / 504 |
| muscle | 96% | 80.14 | 769 / 803 | 0% | 0 | 0 / 0 |
| thymus | 93% | 59.53 | 606 / 653 | 0% | 0.00 | 2 / 605 |
| pancreas | 70% | 66.71 | 230 / 328 | 21% | 0.37 | 38 / 178 |
| intestine | 82% | 48.59 | 790 / 966 | 5% | 0.35 | 26 / 527 |
| heart | 86% | 49.09 | 741 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 83% | 53.22 | 1110 / 1335 | 0% | 0 | 0 / 0 |
| esophagus | 74% | 58.69 | 1070 / 1445 | 7% | 0.48 | 12 / 183 |
| stomach | 72% | 50.10 | 257 / 359 | 8% | 0.67 | 24 / 286 |
| skin | 49% | 25.11 | 884 / 1809 | 8% | 0.42 | 37 / 472 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.46 | 3 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.22 | 2 / 45 |
| peripheral blood | 1% | 1.24 | 12 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_1902035 | Biological process | positive regulation of hematopoietic stem cell proliferation |
| GO_0035855 | Biological process | megakaryocyte development |
| GO_0045654 | Biological process | positive regulation of megakaryocyte differentiation |
| GO_0030219 | Biological process | megakaryocyte differentiation |
| GO_0008283 | Biological process | cell population proliferation |
| GO_0038163 | Biological process | thrombopoietin-mediated signaling pathway |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0097696 | Biological process | cell surface receptor signaling pathway via STAT |
| GO_0043410 | Biological process | positive regulation of MAPK cascade |
| GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005179 | Molecular function | hormone activity |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005125 | Molecular function | cytokine activity |
| GO_0008083 | Molecular function | growth factor activity |
| Gene name | THPO |
| Protein name | Thrombopoietin nirs variant 2 Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand) Thrombopoietin nirs variant 3 Thrombopoietin |
| Synonyms | hCG_40497 MGDF |
| Description | FUNCTION: Lineage-specific cytokine affecting the proliferation and maturation of megakaryocytes from their committed progenitor cells. It acts at a late stage of megakaryocyte development. It may be the major physiological regulator of circulating platelets. |
| Accessions | ENST00000649095.1 ENST00000645603.2 P40225 ENST00000477594.1 ENST00000650229.1 ENST00000647395.1 [P40225-1] ENST00000445696.6 [P40225-2] A0A3B3ITS0 ENST00000421442.2 Q5FBX6 Q5FBX8 Q5FBX4 A0A2R8Y734 F8W6L1 |